BioMimetic Shifts Focus To Ortho Following Dental Combo Product Approval
This article was originally published in The Gray Sheet
Executive Summary
BioMimetic Pharmaceuticals plans to initiate U.S. clinical studies for repairing bone fractures with device-biologic combination products in the first half of 2006